Healthcare provider profile · identity verified

Michael Todd Montgomery, DO

Emergency Medicine · KNOXVILLE, TN · NPI 1336330232

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	1145	96
Eliquis	Apixaban	1098	85
Atorvastatin Calcium	Atorvastatin Calcium	429	94
Amlodipine Besylate	Amlodipine Besylate	262	64
Furosemide	Furosemide	215	61
Trazodone Hcl	Trazodone Hcl	209	44
Metoprolol Tartrate	Metoprolol Tartrate	205	44
Lisinopril	Lisinopril	184	42
Sertraline Hcl	Sertraline Hcl	171	42
Carvedilol	Carvedilol	145	35
Duloxetine Hcl	Duloxetine Hcl	144	32
Baclofen	Baclofen	141	24
Mirtazapine	Mirtazapine	139	35
Ondansetron Hcl	Ondansetron Hcl	137	52
Levetiracetam	Levetiracetam	134	24
Potassium Chloride	Potassium Chloride	119	37
Tamsulosin Hcl	Tamsulosin Hcl	117	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	113	43
Clopidogrel	Clopidogrel Bisulfate	112	26
Divalproex Sodium	Divalproex Sodium	111	25
Farxiga	Dapagliflozin Propanediol	110	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	47
Escitalopram Oxalate	Escitalopram Oxalate	104	21
Tramadol Hcl	Tramadol Hcl	102	30
Xarelto	Rivaroxaban	102	12
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	100	21
Hydralazine Hcl	Hydralazine Hcl	100	25
Donepezil Hcl	Donepezil Hcl	97	25
Metformin Hcl	Metformin Hcl	97	20
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	94	25
Spironolactone	Spironolactone	92	25
Bumetanide	Bumetanide	91	23
Brilinta	Ticagrelor	81	suppressed
Pravastatin Sodium	Pravastatin Sodium	81	18
Fluoxetine Hcl	Fluoxetine Hcl	72	12
Hydroxyzine Hcl	Hydroxyzine Hcl	72	29
Pantoprazole Sodium	Pantoprazole Sodium	72	27
Gabapentin	Gabapentin	70	31
Metoprolol Succinate	Metoprolol Succinate	70	22
Humulin R	Insulin Regular, Human	67	30
Ropinirole Hcl	Ropinirole Hcl	66	12
Losartan Potassium	Losartan Potassium	61	16
Rosuvastatin Calcium	Rosuvastatin Calcium	59	12
Carbidopa-Levodopa	Carbidopa/Levodopa	57	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	56	11
Sucralfate	Sucralfate	55	12
Citalopram Hbr	Citalopram Hydrobromide	54	13
Januvia	Sitagliptin Phosphate	54	suppressed
Entresto	Sacubitril/Valsartan	52	suppressed
Metformin Hcl Er	Metformin Hcl	52	12
Albuterol Sulfate Hfa	Albuterol Sulfate	51	22
Fluticasone Propionate	Fluticasone Propionate	50	17
Gemtesa	Vibegron	48	suppressed
Jardiance	Empagliflozin	48	suppressed
Allopurinol	Allopurinol	45	suppressed
Memantine Hcl	Memantine Hcl	43	16
Alendronate Sodium	Alendronate Sodium	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	42	12
Clonidine	Clonidine	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	33
Risperidone	Risperidone	41	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	40	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	11
Albuterol Sulfate	Albuterol Sulfate	34	suppressed
Ondansetron Odt	Ondansetron	34	21
Montelukast Sodium	Montelukast Sodium	33	14
Valsartan	Valsartan	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	16
Warfarin Sodium	Warfarin Sodium	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	16
Prednisone	Prednisone	28	15
Celecoxib	Celecoxib	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	12
Primidone	Primidone	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	11
Torsemide	Torsemide	24	suppressed
Dapagliflozin	Dapagliflozin Propanediol	23	suppressed
Finasteride	Finasteride	23	suppressed
Hydroxyurea	Hydroxyurea	23	suppressed
Levofloxacin	Levofloxacin	23	18
Propranolol Hcl	Propranolol Hcl	23	suppressed
Ranolazine Er	Ranolazine	23	suppressed
Sulfasalazine	Sulfasalazine	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lactulose	Lactulose	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	14
Famotidine	Famotidine	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Cefdinir	Cefdinir	20	19
Mupirocin	Mupirocin	20	17
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Clonidine Hcl	Clonidine Hcl	19	14
Megestrol Acetate	Megestrol Acetate	19	suppressed
Movantik	Naloxegol Oxalate	19	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	19	19
Lamotrigine	Lamotrigine	18	suppressed
Simvastatin	Simvastatin	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Neupro	Rotigotine	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Estradiol	Estradiol	16	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	16	suppressed
Nyamyc	Nystatin	16	11
Oxcarbazepine	Oxcarbazepine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Prednisolone Acetate	Prednisolone Acetate	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Doxycycline Hyclate	Doxycycline Hyclate	15	14
Methylprednisolone	Methylprednisolone	15	suppressed
Omeprazole	Omeprazole	15	11
Aripiprazole	Aripiprazole	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Travoprost	Travoprost	14	suppressed
Atenolol	Atenolol	13	suppressed
Glipizide	Glipizide	13	suppressed
Glucagon Emergency Kit	Glucagon	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Nystatin	Nystatin	13	13
Sodium Chloride	0.9 % Sodium Chloride	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	11
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Meropenem	Meropenem	12	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	12	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Linzess	Linaclotide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error